Royal (Wuxi) Bio-pharmaceutical Co., Ltd Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2002

Location

Wuxi Jiangsu China

Primary Industry

Biotechnology

About

Based in Wuxi, China and established 2002, Royal (Wuxi) Bio-pharmaceutical Co., Ltd is a biopharmaceutical company that focuses on the development, manufacture and marketing of medicines cover treatment, precautionary and biological reagent area. In September 2021, the company completed strategic investment from Jun Yuan Capital. At present, the company covers an area of more than 100000 square meters, and the total investment in phase I is 25 million dollars. The existing scientific research personnel account for 70% of the company's employees. The company has developed the freeze dried meningococcal conjugate vaccine of group A and group C for children from 6 months to 2 years old.

Current Investors

GTJA Investment Group, Detong Capital, Jun Yuan Capital

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals

Website

www.rbpc.com.cn

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.